1. 1362PSafety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in Japanese patients with NSCLC harboring ROS1 fusion gene. (18th September 2017) Authors: Takeda, M.; Seto, T.; Fujiwara, Y.; Yamamoto, N.; Nosaki, K.; Toyozawa, R.; Abe, C.; Shiga, R.; Nakamaru, K.; Nakagawa, K. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗